Reference answer · 340b-program · reviewed quarterly
Last updated
Review cadence: quarterlyUnderlying federal data: refreshed weekly to annual per source
Q&A library · 340b-program

How are 340B covered entities handling ceiling price disputes under HRSA oversight in 2026?

In 2026, HRSA shifted from passive review to active enforcement, requiring covered entities to verify quarterly ceiling price files and document any overcharge resolutions. Hospitals must now initiate manufacturer refunds, maintain detailed paper trails, and reconcile pricing mismatches promptly to avoid compliance citations during audits.

Related questions.

Q&A librarySourced · reviewed quarterly
340b-programHow is HRSA changing 340B drug diversion oversight for specialty pharmacies in 2026?340b-programHow does HRSA enforce 340B re-registration after hospital mergers in 2026?340b-programHow will HRSA verify 340B child site eligibility during 2026 audits?340b-programHow can hospitals maintain 340B eligibility for offsite clinics in 2026?340b-programHow will HRSA verify 340B patient definition compliance across multi-site systems in 2026?340b-programHow is HRSA enforcing 340B duplicate discount rules for Medicaid MCO claims in 2026?
Browse all canonical questions →